Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4581767 | 0.90 | AR (0.46) | AR | |
| SCHEMBL4796301 | 0.82 | TGM2 (0.50) | ARP4HB | |
| SCHEMBL4798159 | 0.81 | P4HB (0.51) | P4HB | |
| SCHEMBL4795380 | 0.77 | MAPT (0.55) | — | |
| SCHEMBL4797029 | 0.76 | MAPT (0.47) | — | |
| SCHEMBL4778439 | 0.74 | MAOA (0.51) | — | |
| SCHEMBL4782134 | 0.72 | MAP3K7 (0.56) | AR | |
| SCHEMBL4795882 | 0.72 | MAP3K7 (0.56) | — | |
| SCHEMBL4782629 | 0.72 | MAOA (0.46) | P4HB | |
| SCHEMBL4782097 | 0.72 | NPC1 (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008015265-A1 | ANTHRACEN DERIVATIVES AND THEIR USE FOR THE TREATMENT OF BENIGN AND MALIGNANT TUMOROUS DISEASES | ÆTERNA ZENTARIS GMBH (DE) | 2008-02-07 | — | — | WO | claimed |
| WO-2008015265-A1 | ANTHRACEN DERIVATIVES AND THEIR USE FOR THE TREATMENT OF BENIGN AND MALIGNANT TUMOROUS DISEASES | ÆTERNA ZENTARIS GMBH (DE) | 2008-02-07 | — | — | WO | disclosed |